Skip to content

NXGL

NEXGEL, Inc.

NASDAQ · USHealthcareMedical - Instruments & Supplies
$0.45-5.49%

Price as of Jul 20, 2026

NXGL growth

NEXGEL, Inc. growth

Reported trailing growth, forward expectations and three-year compound growth rates.

Trailing growth

Year over year

Revenue
+10.1%
EBITDA
+14.2%
EBIT
-2.1%
EPS
+14.3%
Free cash flow
+58.9%
Operating cash flow
+55.4%

Forward estimates

Revenue
EBITDA
EPS

Three-year CAGR

Revenue
+77.3%
EBITDA
+27.0%
EBIT
+5.7%
Net income
+8.6%
EPS
+24.0%
Free cash flow
+68.0%

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.